StockComparison Logo
vs

GRCE vs BENF

Comparison between Acasti Pharma Inc (GRCE, Company) and Beneficient - Class A (BENF, Company).

GRCE is from the Healthcare sector, while BENF is from the Financial Services sector.

GRCE vs BENF - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
GRCE
$34M
BENF
$34M
Max Drawdown
Winner
GRCE
60.00%
BENF
99.97%
Sharpe Ratio
GRCE
-0.19
Winner
BENF
0.71
5Y Beta
GRCE
0.88
Winner
BENF
0.28
Industry
GRCE
Biotechnology
BENF
Asset Management
P/E Ratio
Winner
GRCE
-3.94
BENF
-0.81
Forward P/E
Winner
GRCE
2.17
BENF
6.93
Debt to Equity
Winner
GRCE
0.00%
BENF
106.91%
Free Cash Flow Yield
GRCE
-26.36%
BENF
N/A
P/S Ratio
GRCE
197.75
Winner
BENF
0.39
P/B Ratio
GRCE
0.69
Winner
BENF
0.21

GRCE vs BENF - Historical Returns

Returns include dividend reinvestment.

1M
Winner
GRCE
-6.09%
BENF
-30.99%
3M
Winner
GRCE
-7.30%
BENF
-40.82%
6M
Winner
GRCE
-49.65%
BENF
-53.65%
1Y
GRCE
-29.64%
Winner
BENF
-22.88%
Max(CAGR)
Winner
GRCE
-16.30%
BENF
-91.38%

GRCE vs BENF - Annual Returns (2023 - 2026)

Returns include dividend reinvestment.

YearGRCEBENF
2026-40.98%-70.33%
2025-13.50%+22.90%
2024+23.84%-98.10%
2023N/A-94.66%

GRCE vs BENF Drawdown Comparison

The maximum drawdown for GRCE was -60.00%, occurring on Apr 7, 2025. Recovery took 323 trading sessions.

The maximum drawdown for BENF was -99.97%, occurring on Apr 21, 2025. This drawdown has not yet recovered.

The current GRCE drawdown is -57.89%. The current BENF drawdown is -99.96%.

RankGRCEBENF
#1-60.00%
Dec 6, 2024 - Mar 25, 2026
-99.97%
Jun 7, 2023 - Apr 21, 2025
#2-59.65%
Apr 2, 2026 - Jul 30, 2026
N/A
#3-18.06%
Oct 23, 2024 - Dec 4, 2024
N/A
#4-8.60%
Mar 26, 2026 - Apr 1, 2026
N/A
#5-5.57%
Oct 10, 2024 - Oct 23, 2024
N/A

Correlation

Correlation between GRCE and BENF is 0.38 which considered as a weak positive correlation - the stocks show a slight tendency to move together.

0.38
-101

Select Stocks to Compare